Skip Navigation


Human Reproduction Update Advance Access first published online on July 28, 2006
This version published online on August 3, 2006
Human Reproduction Update, doi:10.1093/humupd/dml029
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/6/769    most recent
dml029v2
dml029v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Stenman, U.-H.
Right arrow Articles by Valmu, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stenman, U.-H.
Right arrow Articles by Valmu, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received January 23, 2006
Revised May 30, 2006
Accepted June 8, 2006

Article

The classification, functions and clinical use of different isoforms of HCG

Ulf-Håkan Stenman 1 *, Aila Tiitinen 2, Henrik Alfthan 1, and Leena Valmu 1

1 Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
2 Department of Gynecology and Obstetrics, Helsinki University Central Hospital, Helsinki, Finland

* To whom correspondence should be addressed.
Ulf-Håkan Stenman, E-mail: ulf-hakan.stenman{at}hus.fi


  Abstract

HCG is composed of two subunits, HCG{alpha} and HCG{beta}. During early pregnancy, HCG stimulates progesterone production in the corpus luteum, and injection of HCG is widely used to induce ovulation in assisted reproduction treatment (ART). Under experimental conditions, the free subunits have been shown to exert functions other than those of HCG, but the relevance of these remains to be determined. Intact HCG, free subunits and degraded forms of these occur in biological fluids, and determinations of these are important for diagnosis and monitoring of pregnancy, pregnancy-related disorders and several types of cancer. Development of optimal methods for the various forms has been hampered by lack of appropriate standards and expression of the concentrations of the various forms in units that are not comparable. Furthermore, the nomenclature for HCG assays is confusing and in some cases misleading. These problems can now be solved; a uniform nomenclature has been established, and new standards are available for HCG, its subunits HCG{alpha} and HCG{beta}, the partially degraded or nicked forms of HCG and HCG{beta}, and the beta-core fragment. This review describes the biochemical and biological background for the clinical use of determinations of various forms of HCG. The clinical use of HCG and studies on HCG vaccines are briefly reviewed.

Keywords: cancer/Down’s syndrome/HCG isoforms/pregnancy/trophoblastic disease.

This is a new version of this article as an error in the author affiliations section has been corrected.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
C. M. Sturgeon, P. Berger, J.-M. Bidart, S. Birken, C. Burns, R. J. Norman, U.-H. Stenman, and on behalf of the IFCC Working Group on hCG
Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic Gonadotropin
Clin. Chem., August 1, 2009; 55(8): 1484 - 1491.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. M. Gronowski, M. Cervinski, U.-H. Stenman, A. Woodworth, L. Ashby, and M. G. Scott
False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCG{beta} Core Fragment
Clin. Chem., July 1, 2009; 55(7): 1389 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. Lukanova, R. Andersson, M. Wulff, A. Zeleniuch-Jacquotte, K. Grankvist, L. Dossus, Y. Afanasyeva, R. Johansson, A. A. Arslan, P. Lenner, et al.
Human Chorionic Gonadotropin and Alpha-Fetoprotein Concentrations in Pregnancy and Maternal Risk of Breast Cancer: A Nested Case-Control Study
Am. J. Epidemiol., December 1, 2008; 168(11): 1284 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I. Delbaere, S. Vansteelandt, J. Gerris, P. De Sutter, D. De Bacquer, and M. Temmerman
Human chorionic gonadotropin levels in early IVF/ICSI pregnancies are higher in singletons after single embryo transfer compared with singletons after double embryo transfer
Hum. Reprod., November 1, 2008; 23(11): 2421 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Lempiainen, U.-H. Stenman, C. Blomqvist, and K. Hotakainen
Free {beta}-Subunit of Human Chorionic Gonadotropin in Serum Is a Diagnostically Sensitive Marker of Seminomatous Testicular Cancer
Clin. Chem., November 1, 2008; 54(11): 1840 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Z. Cao and R. Rej
Are Laboratories Reporting Serum Quantitative hCG Results Correctly?
Clin. Chem., April 1, 2008; 54(4): 761 - 764.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
U.-H. Stenman
Commentary
Clin. Chem., January 1, 2008; 54(1): 213 - 214.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.